Cargando…
Toxicological Aspects of a Novel 9‐Aminoanthracycline, SM‐5887
The toxicological characteristics of SM‐5887 were evaluated in mice after a bolus intravenous injection, and compared with those of adriamycin (ADR). The acute toxic signs observed after SM‐5887 administration were body weight decrease, ataxia, hair loss, and myelosuppression. They were qualitativel...
Autores principales: | Morisada, Shinya, Yanagi, Yoshikazu, Kashiwazaki, Yasuo, Fukui, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917682/ https://www.ncbi.nlm.nih.gov/pubmed/2496062 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02248.x |
Ejemplares similares
-
Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts
por: Morisada, Shinya, et al.
Publicado: (1989) -
Tumor‐selective Distribution of an Active Metabolite of the 9‐Aminoanthracycline Amrubicin
por: Noguchi, Toshihiro, et al.
Publicado: (1998) -
Cytotoxicity of Amrubicin, a Novel 9‐Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells
por: Yamaoka, Takashi, et al.
Publicado: (1998) -
Uptake and Intracellular Distribution of Amrubicin, a Novel 9‐Amino‐anthracycline, and Its Active Metabolite Amrubicinol in P388 Murine Leukemia Cells
por: Yamaoka, Takashi, et al.
Publicado: (1999) -
In vivo Efficacy and Tumor‐selective Metabolism of Amrubicin to Its Active Metabolite
por: Noguchi, Toshihiro, et al.
Publicado: (1998)